You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (5)

Journals (0)

1-5 of 5 results for flat-dose immunotherapy

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Rethinking centralised oncology pharmacy practice in the era of flat-dose immunotherapy,subcutaneous formulations and visit-administration day separation: A conceptual analysis and reform proposal

Retricted access

Research article

First published 2026

Rethinking centralised oncology pharmacy practice in the era of flat-dose immunotherapy,subcutaneous formulations and visit-administration day separation: A conceptual analysis and reform proposal

Mauro Iannopollo

Journal of Oncology Pharmacy Practice

Select article: Efficacy of nivolumab four-weekly dosing schedule based on body weight

Retricted access

Article commentary

First published 2019-6

Efficacy of nivolumab four-weekly dosing schedule based on body weight

Mário L de Lemos, Carrie Kung, Sally Waignein

Journal of Oncology Pharmacy Practice

Select article: Evaluation of safety outcomes between nivolumab regimens with differing dosing patterns

Open access

Research article

First published 2025-10

Evaluation of safety outcomes between nivolumab regimens with differing dosing patterns

Joseph Elijah, Igor Puzanov, Benjamin Cresanti [...]

Journal of Oncology Pharmacy Practice

Select article: Nivolumab treatment in a patient with BRAF mutant advanced melanoma and liver failure with encephalopathy

Retricted access

Case report

First published 2024-4

Nivolumab treatment in a patient with BRAF mutant advanced melanoma and liver failure with encephalopathy

Rumeysa Colak, Caner Kapar, Ilkay Gulturk [...]

Journal of Oncology Pharmacy Practice

Select article: Rationale and design for a phase IIIb trial of first-line tremelimumab plus durvalumab versus pembrolizumab,in combination with chemotherapy,in patients with non-squamous metastatic non-small-cell lung cancer and mutations or co-mutations in STK11,KEAP1,or KRAS : the TRITON study

Open access

Research article

First published 2025

Rationale and design for a phase IIIb trial of first-line tremelimumab plus durvalumab versus pembrolizumab,in combination with chemotherapy,in patients with non-squamous metastatic non-small-cell lung cancer and mutations or co-mutations in STK11,KEAP1,or KRAS : the TRITON study

Ferdinandos Skoulidis, Hossein Borghaei, Edward B. Garon [...]

Therapeutic Advances in Medical Oncology

1
10 / page

Article type

Publication date

Subjects

Access